ScienceDaily for January 7, 2011 reported on vitamin D and Tuberculosis.
In a trial led by Dr Adrian Martineau of the Centre for Health Sciences at Barts and The London School of Medicine and Dentistry -- and funded by the British Lung Foundation -- 146 patients with drug-sensitive TB were recruited from 10 National Health Service Trusts in London and randomly and evenly assigned to receive either four oral doses of 2.5mg of vitamin D, or a placebo. All participants received standard antibiotic treatment for their condition.
